BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24127822)

  • 1. Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita.
    Ito Y; Kasai H; Yoshida T; Saleh MA; Amagai M; Yamagami J
    J Dermatol; 2013 Nov; 40(11):864-8. PubMed ID: 24127822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions.
    Kim JH; Kim YH; Kim S; Noh EB; Kim SE; Vorobyev A; Schmidt E; Zillikens D; Kim SC
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e224-30. PubMed ID: 22731917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study.
    Marzano AV; Cozzani E; Fanoni D; De Pità O; Vassallo C; Berti E; Parodi A; Crosti C; Cugno M
    Br J Dermatol; 2013 Jan; 168(1):80-4. PubMed ID: 22913489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial epidermolysis bullosa acquisita.
    Noe MH; Chen M; Woodley DT; Fairley JA
    Dermatol Online J; 2008 Dec; 14(12):2. PubMed ID: 19265615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis.
    Terra JB; Jonkman MF; Diercks GF; Pas HH
    Br J Dermatol; 2013 Jul; 169(1):164-7. PubMed ID: 23480491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA).
    Seta V; Aucouturier F; Bonnefoy J; Le Roux-Villet C; Pendaries V; Alexandre M; Grootenboer-Mignot S; Heller M; Lièvre N; Laroche L; Caux F; Titeux M; Hovnanian A; Prost-Squarcioni C
    J Am Acad Dermatol; 2016 Jun; 74(6):1166-72. PubMed ID: 26947449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.
    Kasperkiewicz M; Hirose M; Recke A; Schmidt E; Zillikens D; Ludwig RJ
    Br J Dermatol; 2010 May; 162(5):1064-70. PubMed ID: 20222918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective study of the clinical, histologic, and immunologic features of epidermolysis bullosa acquisita in 9 patients.
    Barreiro-Capurro A; Mascaró-Galy JM; Iranzo P
    Actas Dermosifiliogr; 2013 Dec; 104(10):904-14. PubMed ID: 23895729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.
    Woodley DT; Ram R; Doostan A; Bandyopadhyay P; Huang Y; Remington J; Hou Y; Keene DR; Liu Z; Chen M
    J Invest Dermatol; 2006 Jun; 126(6):1323-30. PubMed ID: 16543893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of experimental epidermolysis bullosa acquisita by immunization with murine collagen VII.
    Sesarman A; Sitaru C
    Methods Mol Biol; 2013; 961():371-87. PubMed ID: 23325658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T and B cells target identical regions of the non-collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita.
    Müller R; Dahler C; Möbs C; Wenzel E; Eming R; Messer G; Niedermeier A; Hertl M
    Clin Immunol; 2010 Apr; 135(1):99-107. PubMed ID: 20093095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita.
    Koga H; Teye K; Yamashita K; Ishii N; Tsuruta D; Nakama T
    Br J Dermatol; 2019 May; 180(5):1107-1113. PubMed ID: 30311191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita.
    Woodley DT; Chang C; Saadat P; Ram R; Liu Z; Chen M
    J Invest Dermatol; 2005 May; 124(5):958-64. PubMed ID: 15854036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita.
    Iwata H; Bieber K; Tiburzy B; Chrobok N; Kalies K; Shimizu A; Leineweber S; Ishiko A; Vorobyev A; Zillikens D; Köhl J; Westermann J; Seeger K; Manz R; Ludwig RJ
    J Immunol; 2013 Sep; 191(6):2978-88. PubMed ID: 23960233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita.
    Komorowski L; Müller R; Vorobyev A; Probst C; Recke A; Jonkman MF; Hashimoto T; Kim SC; Groves R; Ludwig RJ; Zillikens D; Stöcker W; Schmidt E
    J Am Acad Dermatol; 2013 Mar; 68(3):e89-95. PubMed ID: 22341608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.
    Fairley JA; Woodley DT; Chen M; Giudice GJ; Lin MS
    J Am Acad Dermatol; 2004 Jul; 51(1):118-22. PubMed ID: 15243536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature.
    Mayuzumi M; Akiyama M; Nishie W; Ukae S; Abe M; Sawamura D; Hashimoto T; Shimizu H
    Br J Dermatol; 2006 Nov; 155(5):1048-52. PubMed ID: 17034540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
    Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
    J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-course of the change in titre of antibodies against type VII collagen in a patient with epidermolysis bullosa acquisita.
    Sato M; Ishitsuka A; Shibuya Y; Kanoh H; Koga H; Hashimoto T; Seishima M
    Acta Derm Venereol; 2012 Nov; 92(6):693-4. PubMed ID: 22434144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.